image
Healthcare - Biotechnology - NASDAQ - US
$ 56.23
-5.92 %
$ 3.46 B
Market Cap
-13.02
P/E
BALANCE SHEET
333 M ASSETS
-13.00%
163 M LIABILITIES
37.87%
170 M EQUITY
-35.76%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Rhythm Pharmaceuticals, Inc.
image
Current Assets 308 M
Cash & Short-Term Investments 276 M
Receivables 14.9 M
Other Current Assets 17.6 M
Non-Current Assets 24.5 M
Long-Term Investments 0
PP&E 2.12 M
Other Non-Current Assets 22.4 M
Current Liabilities 55.2 M
Accounts Payable 4.88 M
Short-Term Debt 1.54 M
Other Current Liabilities 48.8 M
Non-Current Liabilities 108 M
Long-Term Debt 490 K
Other Non-Current Liabilities 107 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 60.1 127.7 59.2 100.9 62.3 49.5 34.2 6.5 34.9 0.2 7.4 11.8
Short Term Investments 215.8 205.6 235.6 71.9 230.2 202.5 113.8 4.0 0 0 10.4 5.3
Receivables 14.9 6.2 1.0 0 0 0 0 0 0 0 0 0
Inventory 8.6 2.9 0.1 0 0 0 0 0 0 0 0 0
Other Current Assets 8.9 11.8 12.4 8.9 9.9 6.6 2.6 0.6 0.6 42 K 0.4 1.8
Total Current Assets 308.3 354.2 308.4 181.7 302.4 258.7 150.7 11.2 35.5 0.2 18.1 18.9
PP&E 2.1 3.4 4.3 5.0 5.7 1.1 0.8 0.9 17 K 0 24 K 44 K
Intangible Assets 7.0 7.9 4.7 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0.3 0.3 0.4 0.4 0.4 0.2 0.2 0.3 0 0 0
Other Long Term Assets 15.3 17.0 12.1 0 0 0 0 9 K 1.5 0 23 K 23 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 332.7 382.5 329.5 187.1 308.5 260.2 151.7 12.3 37.3 0.2 18.2 18.9
LIABILITIES
Accounts Payable 4.9 4.8 5.7 4.9 10.4 7.6 2.4 1.9 1.4 0.5 1.5 2.2
Short Term Debt 1.5 1.4 1.2 1.1 0.9 0 0 0 0 0 0 0
Other Current Liabilities 47.5 32.2 29.5 12.0 13.1 5.9 4.3 2.8 3.6 17 K 1.6 0.3
Total Current Liabilities 55.2 39.8 43.4 18.0 24.4 13.6 6.7 4.7 5.3 0.6 3.1 2.5
Long Term Debt 0.5 1.3 1.9 2.6 3.1 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 107.3 77.2 0 0 0 0.4 0.2 0.3 0 0 72.6 52.7
Total Liabilities 163.0 118.2 45.4 20.5 27.5 14.0 6.9 5.0 5.3 0.6 75.6 55.2
EQUITY
Common Stock 59 K 56 K 50 K 44 K 44 K 34 K 27 K 10 K 10 K 93 K 53 K 3 K
Retained Earnings (894.7) (710.1) (528.9) (459.3) (325.3) (184.6) (110.3) (76.5) (50.7) (39.6) (58.4) (37.0)
Other Accumulative Comprehensive Income/Loss 0.1 92 K 1 K 49 K 0 (0.8) (0.4) (0.1) 0 0 46 K 26 K
Total Equity 169.8 264.3 284.2 166.5 281.0 246.3 144.8 7.3 32.0 (0.4) (57.5) (36.3)
Total Liabilities and Equity 332.7 382.5 329.5 187.1 308.5 260.2 151.7 12.3 37.3 0.2 18.2 18.9
SHARES OUTSTANDING
Common Shares Outstanding 57.7 52.1 49.6 44.1 36.4 31.0 13.3 16.7 16.7 10.2 50.3 50.3